RxDoctor Payments Data

Ingrid Martinez-Lyons, MD

Psychiatry · Novi, MINPI 1013019710

Payments from drug & device makers

$4,885in general payments, 2019–2025

Across 275 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$952
  • AbbVie$816
  • Otsuka America Pharmaceutical, Inc.$594
  • Lundbeck LLC$531
  • Takeda Pharmaceuticals U.S.A., Inc.$397
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$330
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$4,884100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,885 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$53,577
Medicare patients
55
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl25$37,803
TrintellixVortioxetine Hydrobromide32$23,954
RexultiBrexpiprazole11$15,230
Clozapine49$4,565
Duloxetine Hcl86$3,512
Atomoxetine Hcl14$2,337
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$2,044
Venlafaxine Hcl ErVenlafaxine Hcl63$1,939
Quetiapine Fumarate57$1,859
Clonazepam132$1,658
Bupropion XlBupropion Hcl51$1,510
Methylphenidate ErMethylphenidate Hcl21$1,470
Lamotrigine75$1,416
Buspirone Hcl76$1,414
Triazolam19$1,380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$816$37,80325 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$397$23,95432 claims
Otsuka America Pharmaceutical, Inc.Rexulti$594$15,23011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Novi

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →